ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Gastrointestinal cancers at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

524 organizations at ESMO 2026 present work in gastrointestinal cancers, led by cancer centres and hospitals. Between them they bring 2,742 presentations to the program. Most represented: Gustave Roussy, MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. As of Nov 2, 2026.

All 1,879 organizations at ESMO 2026 →

Format
Top represented
Showing 1–1 of 524 organizations
OrganizationESMO 2026 Attendance
Gustave Roussy
Villejuif, France
Cancer centre & hospital
Comprehensive cancer centre in Villejuif, near Paris, France, affiliated with Paris-Saclay University.
Keynote
Fri Oct 23
11:30–11:38
ESMO Presidential address
ESMO 2026 Opening session
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
GIG-T (GETUG-T07): A phase 3 randomised study assessing thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors
ePoster session 6
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
LEAH: A prospective multi-fluid cohort for cancer risk refinement and early detection
ePoster session 6
Biomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Malnutrition, sarcopenia, hypermetabolism and micronutrient deficiencies at pancreatic cancer diagnosis: The NUTRIPAN cohort
ePoster session 17
Gastrointestinal cancersNursing & supportive care
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Neoadjuvant-based multimodality treatment in rare sinonasal tumors: A single-center cohort
ePoster session 8
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Real-world data in adenoid cystic carcinoma: A retrospective single-center experience
ePoster session 8
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Chair
Fri Oct 23
13:30–15:00
Proffered paper 1: Breast cancer, early and advanced stage
with Memorial Sloan Kettering Cancer Center
Breast cancer
Abstract
Fri Oct 23
14:00–14:10
Invited Discussant LBA23, LBA13 and LBA27
Proffered paper 1: Breast cancer, early and advanced stage
Breast cancer
Talk
Fri Oct 23
14:30–14:50
Therapeutic approaches in advanced/recurrent EC beyond CPIs and ADCs
Update on the mangement of endometrial cancer in the era of molecular classification
Gynaecological cancers
Poster
Fri Oct 23
15:15–16:00
A 25-gene T-cell exhaustion signature refines TLS-based prediction of immunotherapy benefit
Friday Poster Display session 3
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Characterization of the molecular and immune microenvironment landscape of synchronous vs metachronous renal cell carcinoma
Friday Poster Display session 5
Genitourinary cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Genomic landscape and prognostic value of circulating tumor DNA (ctDNA) in pancreatic ductal adenocarcinoma (PDAC): A real-world cohort of 541 patients
Friday Poster Display session 3
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
In search for predictive biomarkers of redifferentiation treatment efficacy
Friday Poster Display session 2
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Talk
Fri Oct 23
16:15–16:35
Novel AR targeted therapies
Emerging therapeutic strategies in advanced prostate cancer
Genitourinary cancers
Abstract
Fri Oct 23
16:25–16:37
Invited Discussant 1243RO and 1244RO
Rapid oral 1: Gynaecological cancers
Gynaecological cancers
Talk
Fri Oct 23
16:30–16:45
Basket trials: When is enough, enough?
Raising the bar for tumor-agnostic studies
Biomarkers & precision oncology
Talk
Sat Oct 24
08:30–08:50
Enhance inclusiveness and patient accrual for clinical trials
Solutions to overcome barriers of access to clinical trials
Talk
Sat Oct 24
08:30–08:50
Presentation by Expert
Sequencing systemic therapies for advanced urothelial cancer
Genitourinary cancers
Chair
Sat Oct 24
08:30–10:00
Solutions to overcome barriers of access to clinical trials
with Netherlands Cancer Institute
Talk
Sat Oct 24
08:40–08:50
Welcome from ESMO
EONS Opening session
Nursing & supportive care
Talk
Sat Oct 24
09:10–09:30
Systemic approach
Challenges in the treatment approach of HPV-related head and neck cancers
Sarcoma, CNS, head & neck and rare cancers
Abstract
Sat Oct 24
09:15–09:25
LBA26 - Short-term preoperative durvalumab for stage I TNBC: First results from the phase II UNLOCK 14 - POP-DURVA trial
Proffered paper 2: Breast cancer, early and advanced stage
Breast cancer
Abstract
Sat Oct 24
09:45–09:55
Invited Discussant 1457O, 1458O and 1459O
Proffered Paper: Haematological malignancies
Haematological malignancies
Talk
Sat Oct 24
11:30–11:37
Table 1
Mentor the Mentor session
Poster
Sat Oct 24
12:00–12:45
Communicating complexity in precision oncology: Qualitative insights to inform patient-facing digital twins
Saturday Poster Display session 5
Biomarkers & precision oncology
Chair
Sat Oct 24
12:00–12:50
ESMO-EACR: What oncologists should know about molecular oncology
with University of Turin, VIB
Biomarkers & precision oncology
Poster
Sat Oct 24
12:00–12:45
Genomic landscape of hormone receptor positive bone-only (BO) and visceral metastases (VM) metastatic breast cancer (HR+ BC)
Saturday Poster Display session 1
Breast cancerBiomarkers & precision oncology
Poster
Sat Oct 24
12:00–12:45
Photobiomodulation as a novel strategy for toxicity prevention in head and neck cancer
Saturday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancersNursing & supportive care
Poster
Sat Oct 24
12:00–12:45
Poster
Sat Oct 24
12:00–12:45
Socio-economic factors (SEF) and use of supportive care (SC) in highly symptomatic patients (pts) with breast cancer (BC)
Saturday Poster Display session 6
Breast cancerNursing & supportive care
Chair
Sat Oct 24
12:00–12:50
What oncologists should know about managing toxicities of novel therapies
with Samsung Medical Center, Hospital Clínic de Barcelona
Nursing & supportive care
Poster
Sat Oct 24
12:00–12:45
Talk
Sat Oct 24
12:15–12:30
Bispecifics
What oncologists should know about managing toxicities of novel therapies
Nursing & supportive care
Talk
Sat Oct 24
12:15–12:30
DNA repair
ESMO-EACR: What oncologists should know about molecular oncology
Biomarkers & precision oncology
Satellite
Sat Oct 24
14:05–14:17
Nuclear Medicine: partner for the Prostate Cancer journey
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Chair
Sat Oct 24
14:45–16:15
Emerging toxicities induced by antibody-drug conjugates
with Odense University Hospital
Nursing & supportive care
Talk
Sat Oct 24
14:45–15:10
Pulmonary toxicities
Emerging toxicities induced by antibody-drug conjugates
Nursing & supportive care
Talk
Sat Oct 24
15:00–15:15
Pheochromocytoma and paraganglioma
Emerging therapies in endocrine and neuroendocrine neoplasms
Sarcoma, CNS, head & neck and rare cancers
Talk
Sat Oct 24
15:15–15:35
How will new technologies contribute to precision medicine?
YO Lecture: What to expect from precision medicine in the next decade
Biomarkers & precision oncology
Talk
Sat Oct 24
15:20–15:35
View of the interventional radiologist
Management of locally advanced HCC
Gastrointestinal cancers
Talk
Sat Oct 24
15:45–16:05
NUT carcinomas, salivary gland cancers and pulmonary blastomas
Updates on rare thoracic tumours
Lung & thoracic cancers
Talk
Sat Oct 24
15:45–16:05
What to do after optimal neoadjuvant therapy?
Optimising treatment for triple negative early breast cancer
Breast cancer
Chair
Sat Oct 24
16:30–18:15
Presidential Symposium I
Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers
Satellite
Sat Oct 24
18:30–20:00
Ipsen - Treatment decisions that shape the journey in RCC and NETs
with University Hospital Erlangen
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
18:30–18:33
Welcome
Ipsen - Treatment decisions that shape the journey in RCC and NETs
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
18:33–18:43
Sequencing in an ever-changing landscape (RCC and NETs)
Ipsen - Treatment decisions that shape the journey in RCC and NETs · with University Hospital Erlangen
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
18:43–19:23
Navigating the RCC treatment journey
Ipsen - Treatment decisions that shape the journey in RCC and NETs · with City of Hope, Arthur Child Comprehensive Cancer Centre
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers
Talk
Sun Oct 25
08:30–08:35
Presentation of case/condition
Using Large Language Models (LLM) in multidisciplinary tumor boards: Practical applications and considerations
Chair
Sun Oct 25
08:30–10:00
Rapid oral 2: NSCLC, metastatic
with Hospital Universitario 12 de Octubre, Centre Léon Bérard
Lung & thoracic cancers
Chair
Sun Oct 25
08:30–10:00
Rapid oral: Developmental therapeutic
with START Center for Cancer Care, University of Oxford
Chair
Sun Oct 25
08:30–09:45
Abstract
Sun Oct 25
08:35–08:40
4245RO - Complementary roles of liquid biopsy and imaging in assessing tumor burden in metastatic cancer
Rapid oral 1: Basic science and translational research
Biomarkers & precision oncology
Abstract
Sun Oct 25
08:45–08:57
Invited Discussant 1006RO, LBA33 and 1007RO
Rapid oral: Developmental therapeutic
Talk
Sun Oct 25
08:55–09:15
Implementation science (incl. Federated learning)
Using Large Language Models (LLM) in multidisciplinary tumor boards: Practical applications and considerations
Abstract
Sun Oct 25
08:57–09:02
4246RO - Microbiome toposcore dynamics following fecal microbiota transplantation in immuno-oncology: A multi-cohort longitudinal analysis
Rapid oral 1: Basic science and translational research
Biomarkers & precision oncology
Abstract
Sun Oct 25
09:29–09:44
Invited Discussant 2618RO, 2652RO and 2680RO
Rapid oral 2: NSCLC, metastatic
Lung & thoracic cancers
Chair
Sun Oct 25
10:15–11:45
AI in cancer care: Transforming treatment, navigating challenges
with Memorial Sloan Kettering Cancer Center
Chair
Sun Oct 25
10:15–11:45
ESMO-ASCO: The evolving definition of the modern oncologist
with Dana-Farber Cancer Institute
Chair
Sun Oct 25
10:15–11:45
Emerging new systemic therapies for RCC
with Ghent University Hospital
Genitourinary cancers
Talk
Sun Oct 25
10:15–10:35
Novel HIF2a targeted agents and combination strategies
Emerging new systemic therapies for RCC
Genitourinary cancers
Talk
Sun Oct 25
10:45–11:00
AI for drug development
AI in cancer care: Transforming treatment, navigating challenges
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Futibatinib, pemigatinib, or lirafugratinib for patients with biliary tract cancers and FGFR alterations
Sunday Poster Display session 3
Gastrointestinal cancers
Satellite
Sun Oct 25
13:05–13:15
Building Bridges in the Management of CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Policlinico Universitario Agostino Gemelli, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:10–13:40
Addressing myths in first treatment choice to optimise outcomes and patient wellbeing in mHSPC
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer · with Cliniques universitaires Saint-Luc
Genitourinary cancers
Satellite
Sun Oct 25
13:15–13:35
Resectable or Not: Navigating the Gray Zones in Advanced CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Policlinico Universitario Agostino Gemelli, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:35–13:50
Defining High-risk CSCC: Identifying Patients Who Need More
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Policlinico Universitario Agostino Gemelli, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:40–13:45
Audience Q&A: Advanced prostate cancer
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer · with Hospital Clínico San Carlos, Cliniques universitaires Saint-Luc
Genitourinary cancers
Talk
Sun Oct 25
13:45–14:00
Rewriting the patient voice with large language models
Digital health, data and innovation
Satellite
Sun Oct 25
13:50–14:20
Timing and Selection of Systemic Therapy in Resectable CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Policlinico Universitario Agostino Gemelli, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
14:20–14:30
Audience Q&A
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Policlinico Universitario Agostino Gemelli, National and Kapodistrian University of Athens +1 more
Melanoma & skin cancers
Chair
Sun Oct 25
14:45–16:25
Proffered paper: Prevention, early detection and intervention
with Memorial Sloan Kettering Cancer Center
Talk
Sun Oct 25
15:10–15:30
Neoadjuvant therapy: A global prescription for cure
More cures in early melanoma
Melanoma & skin cancers
Abstract
Sun Oct 25
16:05–16:15
Invited Discussant 3440O and 3441O
Proffered paper: Prevention, early detection and intervention
Talk
Sun Oct 25
16:30–16:55
Individual cancer risk assessment: A critical appraisal
Pillars of personalised cancer prevention: The breast cancer case
Breast cancer
Abstract
Sun Oct 25
16:42–16:54
Invited Discussant LBA5
Presidential Symposium II
Lung & thoracic cancersGastrointestinal cancers
Talk
Mon Oct 26
08:30–08:50
Chair
Mon Oct 26
08:30–10:00
Early detection and prevention of cancer
with Winship Cancer Institute of Emory University
Chair
Mon Oct 26
08:30–10:00
Navigating the wave of new therapies in gynaecologic cancers
with University Hospitals Leuven
Gynaecological cancers
Abstract
Mon Oct 26
08:40–08:50
Abstract
Mon Oct 26
09:38–09:50
Invited Discussant 3084O, 3893O and 3894O
Proffered paper: Supportive and palliative care
Nursing & supportive care
Chair
Mon Oct 26
10:15–11:45
Addressing the risk of second primary cancers
with Queen Elizabeth Hospital
Nursing & supportive care
Chair
Mon Oct 26
10:15–11:45
Digital health and AI in oncology: Transforming patient monitoring and care
with Vall d'Hebron Institute of Oncology (VHIO)
Talk
Mon Oct 26
10:40–11:05
Integrating patient-reported outcomes in digital health platform
Digital health and AI in oncology: Transforming patient monitoring and care
Poster
Mon Oct 26
12:00–12:45
ENGAGE-OV: T-cell engagers in metastatic ovarian cancer: Clinical and molecular insights from phase I trials
Monday Poster Display session 1
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
GyNEcological versus non gynecological TOXicity patterns in phase I clinical trials (GENE-TOX)
Monday Poster Display session 1
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
Liquid biopsy in fusion-driven NSCLC: Informative rates, resistance detection, and clinical impact
Monday Poster Display session 5
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Systemic proteomics and muscle programs associated with cachexia in resectable head and neck cancer
Monday Poster Display session 2
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Talk
Mon Oct 26
13:25–13:35
From emerging oncologist to independent investigator: A personal journey
ESMO Fellowship Programme: Educational opportunities for young oncologists
Talk
Mon Oct 26
13:35–13:37
The value of ESMO Fellowships: Reflections from the President
ESMO Fellowship Programme: Educational opportunities for young oncologists
Abstract
Mon Oct 26
14:45–14:50
Chair
Mon Oct 26
14:45–15:45
Chair
Mon Oct 26
14:45–16:15
Proffered paper: Non-metastatic NSCLC and other thoracic malignancies
with Erasmus MC
Lung & thoracic cancers
Talk
Mon Oct 26
15:10–15:25
How to simplify the algorithm of treatment of rare endocrine tumors
Endocrine tumours at a glance
Sarcoma, CNS, head & neck and rare cancers
Abstract
Mon Oct 26
15:53–16:05
Invited Discussant LBA64, 2519O and 2511O
Proffered paper: Non-metastatic NSCLC and other thoracic malignancies
Lung & thoracic cancers
Chair
Mon Oct 26
16:30–17:45
Chair
Mon Oct 26
16:30–18:00
IO-based systemic therapy in head and neck cancers
with National Centre for Oncological Hadrontherapy (CNAO)
Sarcoma, CNS, head & neck and rare cancers
Talk
Mon Oct 26
16:30–16:35
Presentation of case/condition
Alleviating total suffering in patients with advanced cancer: It’s time for interdisciplinary interventions
Nursing & supportive care
Abstract
Mon Oct 26
16:42–16:54
Invited Discussant LBA9
Presidential Symposium III
Gynaecological cancersSarcoma, CNS, head & neck and rare cancers
Chair
Tue Oct 27
09:00–13:00
Scientific Congress Highlights 2
with Hospital Clínic de Barcelona
Talk
Tue Oct 27
12:40–13:00
Prevention, early detection and intervention
Scientific Congress Highlights 2

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in gastrointestinal cancers

Tell us what you sell and we’ll find the people at organizations working on gastrointestinal cancers most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ESMO 2026 by

Exhibit hall

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction